2026-10-07

Constellation Brands (STZ) Beats on EPS and Revenue - Stock Drops 4.5% on Weak Guidance Anyway

Written & reviewed by the TradeSmrt editorial team · 2026-10-07

In this article

What Happened
Why a Beat Still Triggered a Sell-Off
What to Take Away From This
FAQ
Sources

What Happened

After the closing bell on Monday, October 6, Constellation Brands (NYSE: STZ) - the beverage alcohol giant behind Mexican import beer brands Modelo and Corona, along with a wine and spirits portfolio - reported fiscal second-quarter 2027 results. Adjusted earnings per share came in at $3.74, beating the Wall Street consensus of $3.61, while revenue reached $2.63 billion against an estimate of $2.54 billion. That represented 6.1% year-over-year revenue growth. On paper, it was a clean earnings beat on both the top and bottom line.

The market's reaction told a different story. In after-hours trading immediately following the report, Constellation Brands shares fell roughly 4.5%. Two things explain why a beat still produced a sell-off. First, operating margin: it came in at 30.6% for the quarter, down sharply from 35.2% in the same period a year earlier. Second, guidance: the company set its fiscal 2027 adjusted EPS outlook at $11.20 to $11.90, a range that sits at or below the Street's consensus of $11.72. Full-year revenue guidance was reaffirmed at roughly $9 billion at the midpoint, but investors clearly weighted the forward profitability outlook more heavily than the quarter that had just beaten expectations.

Inside the beer segment, the picture is split by brand. Newer labels Pacifico and Victoria both posted double-digit depletion (sell-through) growth, while the company's flagship brands, Modelo Especial and Corona Extra, continued to see volumes decline. Total beer depletions slipped slightly overall, meaning growth in the newer brands is only partially offsetting ongoing erosion in the flagships that still generate the bulk of segment profit. Wall Street's response after the print was a familiar combination: hold the rating, cut the price target. Goldman Sachs lowered its target from $196 to $168, UBS cut its target from $205 to $175, and Jefferies trimmed its target from $176 to $167 - even as most analysts kept Buy ratings intact.

Why a Beat Still Triggered a Sell-Off

The first key to this story is tariffs. Constellation Brands generates roughly 84% of its revenue from beer brands imported from Mexico. A 25% tariff the Trump administration imposed on imported canned beer and empty aluminum cans, layered on top of a separate tariff that at one point applied a 50% duty to aluminum imports broadly, has hit the beer segment's cost structure directly. In the prior quarter, tariffs and higher depreciation together compressed beer segment margins by roughly 340 basis points. There was some relief starting in April, when the U.S. government exempted Constellation's products from the aluminum-specific tariff, easing one source of pressure. But the 25% tariff on canned beer itself remains in place. That distinction matters: this quarter's margin compression wasn't a one-time charge, it's a recurring structural cost that will keep showing up until trade policy changes again - which is exactly why the market reacted so sharply the moment the numbers came out.

The second key is a longer-running shift in consumer behavior. In the U.S. and other developed markets, a "sober curious" movement - younger consumers deliberately cutting back on or abstaining from alcohol - has been gaining traction for several years. Layered on top of that, the rapid adoption of GLP-1 weight-loss medications has been linked in multiple reports not just to reduced appetite but to a measurable drop in alcohol cravings among users. Analysts increasingly point to these structural demand shifts as part of the explanation for why Modelo Especial and Corona Extra, Constellation's two largest beer brands by volume, keep posting depletion declines even as the company continues to market them aggressively. The fact that Pacifico and Victoria are growing fast enough to cushion the overall beer segment's volume decline is a genuine positive, but it also means the newer brands are essentially covering for structural softness in the flagship names rather than fundamentally reversing it.

The third key is plain consumer spending weakness. On the earnings call, management and analysts both pointed to softer demand trends across North and South America, unfavorable weather, and a broader slowdown in discretionary consumer spending as additional drags behind the conservative guidance. None of that is unique to Constellation - it's a pattern showing up across the consumer staples and discretionary sectors more broadly this year. Taken together, this episode is a clean illustration of a recurring market dynamic: when a backward-looking metric (last quarter's revenue and EPS) and a forward-looking one (next year's margin and demand trajectory) point in different directions, stock prices tend to follow the forward-looking signal, not the one that already happened. It's a dynamic echoed earlier this year when Nucor and Steel Dynamics - companies that initially looked like tariff winners - saw their stocks drop hard after cutting guidance on softer demand, a reminder that the same policy lever can cut in opposite directions depending on the industry and supply chain involved.

What to Take Away From This

An earnings beat and a rising stock price are not the same thing. Even when EPS and revenue both clear consensus, a stock can fall if operating margin deteriorates year-over-year and forward guidance lands at or below the low end of expectations.
Tariff exposure varies enormously by business model. For a company generating 84% of revenue from Mexican imports, a single tariff policy shift can move quarterly margins by several percentage points - a very different risk profile than a domestically-produced competitor faces.
Structural consumer trends don't show up in a single quarter, but they compound. Slow-moving shifts like the sober curious movement or GLP-1 adoption can be masked for a while by growth in newer brands, but they eventually show up as persistent volume decline in a company's flagship products.
"Maintain Buy, cut price target" is a common analyst combination. Goldman Sachs, UBS, and Jefferies all kept bullish ratings while lowering targets - a signal that the long-term thesis is intact even as near-term earnings visibility has gotten murkier.

FAQ

Why did Constellation Brands stock fall after a good earnings report?

Revenue and EPS both beat Wall Street estimates, but operating margin fell from 35.2% to 30.6% year-over-year, and fiscal 2027 EPS guidance landed at or below the consensus estimate. Investors reacted more strongly to the deteriorating margin trend and the cautious forward outlook than to the quarter that had already beaten expectations.

Why do tariffs hit this company so much harder than other alcohol makers?

Roughly 84% of Constellation Brands' revenue comes from Mexican import beer brands like Modelo and Corona. Tariffs on imported canned beer and aluminum cans add directly to the cost of goods sold for that business, making the company far more tariff-sensitive than competitors who brew primarily in the United States.

How much does the "sober curious" trend actually matter for the stock?

It's a structural, long-term variable rather than something that shows up in a single quarter. Persistent depletion declines in flagship brands like Modelo Especial and Corona Extra are increasingly attributed in part to shifting drinking habits among younger consumers, so investors will keep watching whether newer brands like Pacifico can offset that decline indefinitely or only temporarily.

Sources

This article is an original synthesis and analysis based on the reporting below, not a reproduction of the original articles. Please verify the latest figures and details directly with the source reporting.

⚠️ This article is for informational purposes only and does not constitute investment advice. Market conditions change constantly - always verify the latest information before making investment decisions.